A detailed history of Versant Capital Management, Inc transactions in Artivion, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 920 shares of AORT stock, worth $25,649. This represents 0.01% of its overall portfolio holdings.

Number of Shares
920
Previous 1,010 8.91%
Holding current value
$25,649
Previous $26,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

SELL
$25.41 - $30.11 $2,286 - $2,709
-90 Reduced 8.91%
920 $26,000
Q4 2023

Jan 08, 2024

SELL
$12.33 - $18.83 $5,745 - $8,774
-466 Reduced 31.57%
1,010 $18,000
Q2 2023

Jul 10, 2023

SELL
$12.78 - $17.23 $2,786 - $3,756
-218 Reduced 12.87%
1,476 $25,000
Q1 2023

Apr 10, 2023

BUY
$11.74 - $14.12 $7,161 - $8,613
610 Added 56.27%
1,694 $22,000
Q4 2022

Jan 25, 2023

BUY
$10.01 - $13.9 $10,850 - $15,067
1,084 New
1,084 $0
Q3 2022

Dec 30, 2022

SELL
$13.31 - $23.25 $3,101 - $5,417
-233 Closed
0 $0
Q2 2022

Aug 02, 2022

SELL
$15.73 - $22.91 $1,525 - $2,222
-97 Reduced 29.39%
233 $4,000
Q1 2022

Apr 29, 2022

BUY
$16.95 - $21.74 $1,678 - $2,152
99 Added 42.86%
330 $7,000
Q4 2021

Jan 06, 2022

SELL
$17.19 - $22.84 $206 - $274
-12 Reduced 4.94%
231 $5,000
Q3 2021

Oct 29, 2021

SELL
$22.29 - $28.7 $312 - $401
-14 Reduced 5.45%
243 $5,000
Q2 2021

Jul 22, 2021

BUY
$22.32 - $32.07 $1,071 - $1,539
48 Added 22.97%
257 $7,000
Q4 2020

Feb 08, 2021

SELL
$16.76 - $23.74 $67 - $94
-4 Reduced 1.88%
209 $4,000
Q3 2020

Nov 02, 2020

SELL
$16.35 - $21.4 $408 - $535
-25 Reduced 10.5%
213 $3,000
Q2 2020

Jul 16, 2020

SELL
$16.34 - $25.24 $457 - $706
-28 Reduced 10.53%
238 $4,000
Q1 2020

Apr 17, 2020

BUY
$14.66 - $30.57 $3,899 - $8,131
266 New
266 $4,000
Q1 2019

Apr 23, 2019

SELL
$25.85 - $30.47 $1,008 - $1,188
-39 Closed
0 $0
Q4 2015

Apr 23, 2018

BUY
N/A
39
39 $0

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.12B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.